期刊文献+

羟基喜树碱对人咽鳞癌细胞系FaDu增殖、迁移、凋亡及周期的影响 被引量:4

Effect of Hydroxycamptothecin on proliferation,migration,cellcycle distribution and apoptosis in human pharyngeal squamous carcinoma cell line FaDu
下载PDF
导出
摘要 目的探讨羟基喜树碱对人咽鳞癌细胞系FaDu增殖、迁移、凋亡及周期的影响。方法培养人咽鳞癌细胞系FaDu,采用MTT实验、Transwell细胞迁移实验和流式细胞仪检测不同浓度的羟基喜树碱对FaDu细胞增殖、迁移、凋亡及周期的影响。结果 MTT实验、Transwell侵袭实验结果表明一定浓度羟基喜树碱可以抑制Fadu细胞的增殖和迁移能力,流式细胞仪检测结果显示80μg/L羟基喜树碱可以将FaDu细胞阻滞在S期并促进其凋亡。结论羟基喜树碱可以抑制FaDu细胞的增殖和迁移能力并诱导其凋亡,且羟基喜树碱对FaDu的凋亡诱导作用与其对FaDu细胞周期的影响有关。 Objective To investigate the effect of Hydroxycamptothecin on the proliferation,apoptosis,migration and distribution of the cellcycle in FaDu after exposed to HCPT. Methods Human pharyngeal squamous carcinoma cell line FaDu was cultivated. The growth inhibition was evaluated by MTT assay and the migration was measured by Transwell migration assay. The apoptosis and the cell cycle distribution were detected by flow cytometry after the treatment with HCPT. Results MTT and Transwell experiments showed that certain concentration of HCPT could effectively inhibit the growth and migration of cell line FaDu. According to the results of flow cytometry,the cell cycle was arrested in S phase and apoptosis was obviously induced after treated with HCPT( 80 μg / L). Conclusion HCPT can inhibit the growth and migration of cell line FaDu and induce its apoptosis. HCPT induced apoptosis of the cell cycle in FaDu is probably connected with its effect on the cell cycle of FaDu.
出处 《口腔医学》 CAS 2017年第2期102-105,共4页 Stomatology
基金 国家自然科学基金(30772428,81072230)
关键词 羟基喜树碱 人咽鳞癌细胞系FaDu 凋亡 Hydroxycamptothecin human pharyngeal squamous carcinoma cell line FaDu apoptosis
  • 相关文献

参考文献3

二级参考文献47

  • 1潘显道,王存英.天然抗肿瘤药喜树碱衍生物的研究进展[J].药学学报,2003,38(9):715-720. 被引量:30
  • 2Ferlay J, Shin HR, Bray F, et al. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008 [J]. Int J Can- cer, 2010, 127(12): 2893-2917.
  • 3Gr S goire V, Lefebvre JL, Licitra L, et al. Squamous cell carcinoma of the head and neck: EHNS-ESMO-ESTRO Clinical Practice Guidelines for diagnosis, treatment and follow-up [J]. Ann Oncol, 2010, 21 Suppl 5: v184-186.
  • 4Forastiere AA, Zhang Q, Weber RS, et al. Long-term results of RTOG 91-11: a comparison of three nonsurgical treat- ment strategies to preserve the larynx in patients with lo- cally advanced larynx cancer [J]. J Clin Oncol, 2013, 31(7): 845-852.
  • 5Cohen EEW, Karrison T, Kocherginsky M, et al. DECIDE: A phase m randomized trial of docetaxel (D), cisplatin (P), 5-fluorouracil (F) (TPF) induction chemotherapy (IC) in patients with N2/N3 locally advanced squamous cell car- cinoma of the head and neck (SCCHN) [ C ]. J Clin Oncol (Meeting Abstracts), 2012, 30(15_suppl): 5500.
  • 6Haddad R, O'Neill A, Rabinowits G, et al. Induction chemotherapy followed by concurrent chemoradiother- apy (sequential chemoradiotherapy) versus concurrent chemoradiotherapy alone in locally advanced head and neck cancer (PARADIGM): a randomised phase 3 trial [J]. Lancet Oncol, 2013, 14(3): 257-264.
  • 7Hitt R, Grau JJ, L 6 pez-Pousa A, et al. A randomized phase III trial comparing induction chemotherapy followed by chemoradiotherapy versus chemoradiotherapy ahme as treatment of unresectable head and neck cancer [J]. Ann Oncol, 2014, 25(1): 216-225.
  • 8Blanchard P, Bourhis J, Lacas B, et al. Taxane-cisplatin- fluorouracil as induction chemotherapy in locally advanced head and neck cancers: an individual patient data meta- analysis of the meta-analysis of chemotherapy in head and neck cancer group [J]. J Clin Oncol, 2013, 31(23): 2854-2860.
  • 9Lefebvre JL, Andry G, Chevalier D, et al. Laryngeal pres- ervation with induction chemotherapy for hypopharyngeal squamous cell carcinoma: lO-year results of EORTC trial 24891 [J]. Ann Oncol, 2012, 23(10): 2708-2714.
  • 10Tahara M, Kiyota N, Mizusawa J, et al. Phase II trial of chemoradiotherapy with S-1 plus cist)latin for unresect- able locally advanced head and neck cancer (JCOG0706) [J]. Cancer Sci, 2015, 106(6): 726-733.

共引文献28

同被引文献39

引证文献4

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部